{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/soleno-therapeutics-presents-new-vykat-xr-diazoxide-choline-data-at-endo-2026-demonstrating-meaningful-and-durable-improvements-in-hyperphagia-and-behavioral-symptoms-in-prader-willi-syndrome-following-randomized-withdrawal-per-302799792.html", "message": "News view counter 799910 successfully enlarged"}